Advanced Biomed Inc.
For the period ended Jun 30, 2026. Filed Jun 4, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 30, 2026 · Filed Jun 4, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
Advanced Biomed Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required. |
|---|---|
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
ADVANCED BIOMED INC.
No. 689-85 Xiaodong Road, Yongkang District
886-6-3121716
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JUNE 30, 2026
To the Stockholders of Advanced Biomed Inc.:
NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the “Annual Meeting” or “Meeting”) of Advanced Biomed Inc., a Nevada corporation (the “Company”, “ADVB”, “we”, “us”, or “our”), will be held on June 30, 2026, at 10:00 a.m. Eastern Time, at No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan, unless postponed or adjourned to a later date. At the Annual Meeting, stockholders will act on the following matters:
| Proposal No. 1: | To elect five (5) directors to serve on our Board of Directors until the next annual meeting of stockholders and until their respective successors are duly elected and qualified (“Election of Directors”); |
|---|---|
| Proposal No. 2: | To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in this proxy statement (“Advisory Vote on Executive Compensation”); |
| Proposal No. 3: | To recommend, on a non-binding, advisory basis, the frequency of stockholder advisory votes on the compensation of the Company’s named executive officers (every one year, two years, or three years) (“Advisory Vote on Frequency of Executive Compensation Vote”); |
| Proposal No. 4: | To ratify the appointment of WWC, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026 (“Ratification of Independent Registered Public Accounting”); and |
| Proposal No. 5: | To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies in favor of any of the foregoing proposals (“Adjournment”). |
These items of business are more fully described in the proxy statement accompanying this notice. Only holders of record of shares of our common stock, par value $0.001 per share, at the close of business on May 29, 2026 (the “Record Date”), are entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof.
A list of stockholders entitled to vote at the Annual Meeting will be available for inspection at our principal executive offices for a period of at least ten (10) days prior to the Annual Meeting during normal business hours.
YOUR VOTE IS IMPORTANT. Whether or not you plan to attend the Annual Meeting, we urge you to submit your proxy or voting instructions as soon as possible. Instructions on how to vote are included in the proxy statement. Even if you have submitted your proxy before the meeting, you may still attend and vote at the meeting, in which case your proxy will be revoked automatically.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE:
| “FOR” each nominee | for Proposal No. 1 (Election of Directors) |
|---|---|
| “FOR” | for Proposal No. 2 (Advisory Vote on Executive Compensation — Say-on-Pay) |
| “ONE YEAR” | for Proposal No. 3 (Frequency of Future Advisory Votes on Executive Compensation) |
| “FOR” | for Proposal No. 4 (Ratification of Appointment of Independent Registered Public Accounting Firm) |
| “FOR” | for Proposal No. 5 (Adjournment) |
By Order of the Board of Directors,
Xiaomin Chen, Ph.D.
Chairman of the Board and Chief Executive Officer
June 4, 2026
TABLE OF CONTENTS
| Page | |
|---|---|
| QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND VOTING | 2 |
| PROPOSAL NO. 1 — ELECTION OF DIRECTORS | 6 |
| PROPOSAL NO. 2 — ADVISORY VOTE ON EXECUTIVE COMPENSATION | 13 |
| PROPOSAL NO. 3 — ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS | 15 |
| PROPOSAL NO. 4 — RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 16 |
| PROPOSAL NO. 5 — ADJOURNMENT | 18 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 19 |
| EXECUTIVE COMPENSATION | 20 |
| CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 24 |
i
ADVANCED BIOMED INC.
No. 689-85 Xiaodong Road, Yongkang District
886-6-3121716
PROXY STATEMENT FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON JUNE 30, 2026
This proxy statement is being furnished to stockholders of Advanced Biomed Inc., a Nevada corporation (the “Company”, “ADVB”, “we”, “us”, or “our”), in connection with the solicitation of proxies by and on behalf of our Board of Directors (the “Board”) for use at our Annual Meeting of Stockholders (the “Annual Meeting”) to be held on June 30, 2026, at 10:00 a.m. Eastern Time, at No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan, and at any adjournment or postponement thereof.
In April 2026, the Company completed a leadership transition with the appointment of Xiaomin Chen as Chairman of the Board and Chief Executive Officer, effective April 28, 2026. The Company also completed the acquisition of Acellent Technologies (Hong Kong) Co. Limited, an artificial intelligence company focused on large language models, and trustworthy AI verification systems for regulated financial markets.
This proxy statement, the notice of annual meeting, and the accompanying proxy card are first being mailed or made available to our stockholders on or about June 10, 2026.
Copies of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, including the financial statements and financial statement schedules included therein, accompany this proxy statement. Our Annual Report on Form 10-K is not part of the proxy soliciting material.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.